Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:phenobarbital
|
| gptkbp:availability |
Generic and brand options
|
| gptkbp:brand |
Luminal
Phenobarbital Sodium Elixir |
| gptkbp:category |
gptkb:D
|
| gptkbp:clinical_trial |
Control of seizures in dogs and cats
Long-term management of epilepsy Sedation before surgery Short-term management of anxiety |
| gptkbp:contraindication |
gptkb:Porphyria
Severe liver disease Hypersensitivity to barbiturates |
| gptkbp:dosage_form |
gptkb:microprocessor
|
| gptkbp:duration |
6 to 12 hours
|
| gptkbp:excretion |
Kidneys
|
| gptkbp:form |
gptkb:item
|
| gptkbp:has_ability |
40 mg/5 m L
20 mg/5 m L |
| gptkbp:historical_event |
Introduced in the 1910s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Phenobarbital Elixir
|
| gptkbp:indication |
gptkb:Anxiety
gptkb:Insomnia Preoperative sedation Status epilepticus |
| gptkbp:ingredients |
Phenobarbital
C12 H12 N2 O3 |
| gptkbp:interacts_with |
Alcohol
Anticoagulants CNS depressants |
| gptkbp:is_atype_of |
N03 A A02
|
| gptkbp:is_used_for |
Seizure control
|
| gptkbp:legal_issue |
Prescription only
|
| gptkbp:manager |
Oral
|
| gptkbp:manufacturer |
gptkb:Various
|
| gptkbp:metabolism |
Liver
|
| gptkbp:name |
Essential Medicines
|
| gptkbp:population |
Avoid alcohol
Do not stop abruptly Report any unusual side effects Take as prescribed |
| gptkbp:premiered_on |
30 minutes to 1 hour
|
| gptkbp:side_effect |
gptkb:Nausea
Allergic reactions Dizziness Drowsiness Respiratory depression Dependence Withdrawal symptoms Cognitive impairment |
| gptkbp:social_structure |
Barbiturate
|
| gptkbp:storage |
Room temperature
|
| gptkbp:type_of |
50-06-6
|